Fjarde Ap Fonden Sarepta Therapeutics, Inc. Transaction History

Fjarde Ap Fonden

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $1.87 Million - $2.34 Million	-27,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $43,350 - $101,370	600 Added 2.27%	27,000 $2.01 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $50,224 - $71,496	400 Added 1.54%	26,400 $4.5 Million
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $292,376 - $396,382	2,300 Added 9.7%	26,000 $3.65 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $232,500 - $429,250	-2,500 Reduced 9.54%	23,700 $3.8 Million
Q1 2020 May 11, 2020	BUY	$82.38 - $131.64 $49,428 - $78,983	600 Added 2.34%	26,200 $2.56 Million
Q4 2019 Feb 10, 2020	BUY	$76.53 - $135.58 $229,590 - $406,740	3,000 Added 13.27%	25,600 $3.3 Million
Q3 2019 Oct 31, 2019	BUY	$72.81 - $156.91 $1.65 Million - $3.55 Million	22,600 New	22,600 $1.7 Million

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

Stay updated on Fjarde Ap Fonden with notifications on news.